Conclusion Influenza vaccines do not cause multiple sclerosis (MS). Other vaccines currently routinely recommended to the general population in the U.S.* have not been shown to cause MS. Epidemiological
Conclusion The AS03-adjuvanted 2009 pandemic H1N1 influenza vaccine (trade name: PandemrixTM) was associated with an increased risk of narcolepsy in several northern European countries. In
Vaccines currently routinely recommended to the general population in the U.S.* have not been shown to cause serum sickness.
Institute for Vaccine Safety
Johns Hopkins Bloomberg School of Public Health
615 N Wolfe Street
Baltimore, MD 21205
USA
info@vaccinesafety.edu
All rights reserved.
© 2023 Institute for Vaccine Safety
This website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Member since 2006